PTGS1 and Familial adenomatous polyposis: The administration of low-dose Aspirin to FAP patients caused virtually complete inhibition of serum TXB2 (98.7 ± 1.0%; a marker of platelet COX-1 activity) (Figure 3B) 24 h after the last dose of the drug.